-
CANADA-EN
North America
South America
Europe
Middle East / Africa
Asia / Pacific
BD Nano™ PRO Pen Needles
embecta offers a full portfolio of pen needles and educational resources to support you
- Overview
Did you know that how insulin is injected can be critical to help obtain the full benefits of the medication?¹ A recent study showed that people with diabetes were making at least 1 mistake in how they inject insulin. The most common mistake was using too much force against the skin when injecting.² This can result in accidentally injecting into the muscle layer, which can make an injection more painful and lead to insulin not working as it should.1
Contoured Base
BD Nano™ PRO 4mm Pen Needles have a unique contoured needle base that corrects for the different forces that may be applied to the skin when giving an injection to help make sure insulin gets where it needs to go.2,3
Consistency
With the innovative contoured needle base, the BD Nano™ PRO 4mm Pen Needles can lower the risk of injecting into your muscle by 2-8x vs other 4mm pen needles with a posted base.3†
Confidence
BD Nano™ PRO 4mm Pen Needles have ultra-thin wall technology to increase the flow of insulin so less thumb pressure is needed to push the pen button—making it easier for you to give the injection and giving you confidence that you have received the full dose of insulin.4*
Comfort
The BD Nano™ PRO 4mm pen needle was found by people with diabetes to significantly reduce overall injection pain and make the injection experience easier compared to other 4mm pen needles with a posted base.5^
Ease of Use
BD Nano™ PRO 4mm Pen Needles have an ergonomic design proven to make them easier to use from attachment through disposal. 5^
Single Use
Use a new pen needle every time you inject. Pen needles are recommended to be used only once and are no longer sterile after that. There is an association between needle reuse and injection pain or bleeding.1
† Based on mathematical calculations and not clinical study data compared to other 4mm pen needles.
*Patients were unblinded to the pen needle they were using.
^Results from clinical study assessing patient preferences and feedback.
1. Frid AH, et al. New Insulin Delivery Recommendations. Mayo Clinic Proceedings. 2016;91(9):1231–1255
2. Bari B, Corbeil MA, Farooqui H, et al. Insulin injection practices in a population of Canadians with diabetes: an observational study. Diabetes Ther. 2020;11(11):2595-2609.
3. Rini CR, Roberts BC, Morel D, et al. Evaluating the Impact of Human Factors and Pen Needle Design on Insulin Pen Injection. J Diabetes Sci Technol. 2019;13(3):533-545
4. Aronson R, Gibney MA, Oza K, et al. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings. Clin Ther. 2013;35(7):923-933.
5. Whooley S, Briskin T, Gibney MA, et al. Evaluating the User Performance and Experience with a Re-Engineered 4 mm x 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles. Diabetes Ther. 2019;10(2):697-712.
embecta, formerly part of BD. BD is the manufacturer of the advertised products.